Factor Information
Data ID 1272
Factor moderate/severe non-systemic ventricular dysfunction
Description Multiple conditional logistic regression demonstrated more fQRS (OR 2.9, 95% CI 1.5–5.8; p=0.002), non-systemic ventricular dysfunction (OR 5.1, 95% CI 2.1–12.4; p<0.001) and more prolonged QRS complexes (OR 2.8, 95% CI 1.3–6.2; p=0.011) in VTA patients.
Biomarker NA
Classification A3 (clinical factor - disease & symptom)
Association
Application prognosis and risk assessment
Objective non-systemic ventricular dysfunction
p Value <0.001
OR >5.0
Conclusion the presence of fQRS on ECG may be a useful tool in daily clinical practice to identify patients at risk for developing VTA in patients with CHD, in addition to known predictors of VTA
Risk Factor risk factor
CHD Type
ID 510
CHD Type isolated CHD
CHD Subtype AV/ASD/ccTGA/CoA/EA/PA/PDA/PS/TGA/TOF/UVH/VSD
Reference
PMID 27780553
Year 2016
Title Usefulness of Fragmented QRS Complexes in Patients With Congenital Heart Disease to Predict Ventricular Tachyarrhythmias.
Sample
Population Adults
Source Data
Region Rotterdam, Netherlands
Method retrospective case-control study
Race Europe
Disease History N/A
Treatment History N/A
Group ventricular tachyarrhythmia (VTA)(Treatment) controls(Control)
Number 34(total:139) 14(total:219)
Age mean age: 39±14 years mean age: 38±14 years
Gender (Male: Female) N/A N/A
Marker Level 34(33%) 14 (9%)